Find a Provider

Naomi B. Haas, MD

Naomi B. Haas, MD Physician

Director, Prostate and Kidney Cancer Program
Associate Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Haas is a Penn Medicine employed physician.

About Dr. N Haas

Recognized by America's Top Doctors, 2008, 2010-14

Recognized by Best Doctors in America 2009-2010, 2011-2012

Recognized in Philadelphia Magazine's 2010 Top Docs issue

Clinical Specialties

Specialties:

  • Medicine
    • Medical Oncology

Programs & Services:

  • Cancer
    • Bladder Cancer
    • Kidney Cancer
    • Penile Cancer
    • Prostate Cancer
    • Testicular Cancer
    • Urethral Cancer

Board Certification:

  • Internal Medicine, 1988
  • Medical Oncology, 1995

Conditions & Treatments:

  • Bladder Cancer
  • Cancer Clinical Trials
  • cancer therapy
  • Kidney Cancer
  • malignant melanoma
  • Penile Cancer
  • Prostate Cancer
  • Testicular Cancer
  • ureter cancer
  • Urethral Cancer

Practice Locations and Appointments

  • Genito-urinary Oncology

    Abramson Cancer Center Perelman Center for Advanced Medicine, West Pavilion, 4th Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-PENN (7366)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Northeastern Ohio University - College of Medicine
Residency: Abington Memorial Hospital
Fellowship: Fox Chase Cancer Center

Memberships

American Association for Cancer Research, International American Society of Clinical Oncology, International Eastern Cooperative Oncology Group (Melanoma Committee, Genitourinary Committee), National Eastern Cooperative Oncology Group, National

Affiliation

Dr. Haas is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Mamtani R, Pfanzelter N, Haynes K, Finkelman BS, Wang X, Keefe SM, Haas NB, Vaughn DJ, Lewis JD: Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas. Diabetes Care : 2014.

Haas, NB, Nathanson, KL: Hereditary kidney cancer syndromes Adv Chronic Kidney Dis : 2014.

Haas NB, Quirt I, Hotte S, McWhirter E, Polintan R, Litwin S, Adams PD, McBryan T, Wang L, Martin LP, vonMehren M, Alpaugh RK, Zweibel J, Oza A: Phase II trial of Vorinostat in advanced melanoma Investigational New Drugs : 2014.

Kalbasi A, June CH, Haas N, Vapiwala N.: Radiation and immunotherapy: a synergistic combination. J Clin Invest. : 2013.

Smith DC, Smith MR, Sweeney C, Elfiky AA, Logothetis C, Corn PG, Vogelzang NJ, Small EJ, Harzstark AL, Gordon MS, Vaishampayan UN, Haas NB, Spira AI, Lara PN Jr, Lin CC, Srinivas S, Sella A, Schöffski P, Scheffold C, Weitzman AL, Hussain M.: Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial. J Clin Oncol : 2013.

Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM, Rini BI, Srinivas S, Stein MN, Adams LM, Ottesen LH, Laubscher KH, Sherman L, McDermott DF, Haas NB, Flaherty KT, Ross R, Eisenberg P, Meltzer PS, Merino MJ, Bottaro DP, Linehan WM, Srinivasan R.: Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma J Clin Oncol : 2013.

Jang JW, Hwang WT, Guzzo TJ, Wein AJ, Haas NB, Both S, Vapiwala N.: Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA. Int J Radiat Oncol Biol Phys : 2012.

Haas Naomi B, Lin Xinyi, Manola Judith, Pins Michael, Liu Glenn, McDermott David, Nanus David, Heath Elisabeth, Wilding George, Dutcher Janice: A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802. Medical oncology (Northwood, London, England) 29 (2): 761-7,2012.

Swisher-McClure S, Pollack CE, Christodouleas JP, Guzzo TJ, Haas NB, Vapiwala N, Bekelman JE: Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys : 2012.

Swisher-McClure Samuel, Pollack Craig E, Christodouleas John P, Guzzo Thomas J, Haas Naomi B, Vapiwala Neha, Bekelman Justin E: Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. International journal of radiation oncology, biology, physics 83 (1): 8-15,2012.

Academic Contact Info

16 Penn Tower
3400 Spruce Street

Philadelphia, PA 19104
Phone: (215) 662-7402
Fax: (215) 349-8550
Patient appointments: 800-789-PENN (7366)

Related Links